-
Ozempic gets India nod: Drug regulator approves Novo Nordisk’s blockbuster diabetes drug
26 Sep 2025 19:22 GMT
… (CDSCO) has granted approval to Novo Nordisk’s blockbuster drug, Ozempic (Semaglutide … noted.
Ozempic, marketed by Novo Nordisk in India, is primarily indicated … Managing Director of Novo Nordisk, highlighted the therapy’s clinical benefits and potential …
-
Consumers Splurge, Intel, GlobalFoundries, Lilly, Paccar, American Woodmark Benefit From New Tariffs
26 Sep 2025 15:28 GMT
To gain an edge, this is what you need to know today.
New Tariffs
Please click here for a chart of SPDR S&P 500 ETF Trust (NYSE: SPY) which represents the benchmark stock market index S&P 500 (SPX).
Note the following:
The chart shows there is …
-
3 Reasons to Buy Novo Nordisk Stock Right Now
25 Sep 2025 12:36 GMT
… even higher.
Meanwhile, Novo Nordisk is also preparing regulatory … estimates.
Beyond that, Novo Nordisk has several candidates that … its pipeline further. Novo Nordisk aims to stay competitive … But considering the numerous benefits of these therapies, which …
-
<![CDATA[Tirzepatide Is A ‘Ray of Hope’ for Patients with OSA: Referral Uptick, Who Benefits]]>
26 Sep 2025 02:03 GMT
Ever since the US Food & Drug Administration (FDA) approved tirzepatide (Zepbound) for obstructive sleep apnea (OSA) last December, there has been an increase in OSA referrals.1
Tripeptide’s FDA approval, announced by Eli Lilly and Company on December …
-
Bill Gates, Novo Nordisk Foundation Renew Project to Turn Carbon Into Food with $26M Investment
24 Sep 2025 03:53 GMT
… dioxide.
Now, Gates Foundation and Novo Nordisk Foundation have renewed the initiative … , and share our findings to benefit communities and industries worldwide,” she … presidency of the European Council.
Novo Nordisk Foundation, meanwhile, has already been …
-
Expanding GLP-1 horizons: Novo Nordisk leads MASH therapeutic race
23 Sep 2025 18:09 GMT
On 15 August 2025, Novo Nordisk’s Wegovy (semaglutide 2.4mg) … , positioning Novo Nordisk as a first mover in combining systemic metabolic benefits with …
-
Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (Sept 2025)
22 Sep 2025 15:31 GMT
… , including amycretin and CagriSema. Novo Nordisk has reported promising clinical trial … Danish manufacturer, Novo Nordisk A/S (NYSE: NVO).
Novo Nordisk sees the obesity … and logistical flexibility will reap benefits through geopolitical risk mitigation …
-
Weight-loss drug Ozempic to debut in India soon
26 Sep 2025 22:46 GMT
… demand for its significant benefits in patients with obesity … this year. Sources said Novo Nordisk recently received the government … first three months.
A Novo Nordisk spokesperson confirmed the development … experts told ET the benefits of Ozempic extends beyond …
-
How the FDA’s crackdown on pharma ads may play out legally
26 Sep 2025 23:14 GMT
… worked as general counsel for Novo Nordisk and Daiichi Sankyo.
Some of … — and that pharma ads have benefits for public health.
While the …
-
FDA approves first once-daily oral treatment for acromegaly
26 Sep 2025 21:33 GMT
… provide disease and product education, benefit verification, financial assistance resources and … and consulting for Crinetics and Novo Nordisk. Sisco reports no relevant financial …